Stay updated on OMS721 Compassionate Use in TMA Clinical Trial
Sign up to get notified when there's something new on the OMS721 Compassionate Use in TMA Clinical Trial page.

Latest updates to the OMS721 Compassionate Use in TMA Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedAdded Thrombotic thrombocytopenic purpura to the study keyword terms and updated the page revision from v3.4.1 to v3.4.2.SummaryDifference0.2%

- Check18 days agoChange DetectedRevision: v3.4.1 is now displayed, replacing the previous v3.4.0. The page content, including study details and eligibility criteria, remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check32 days agoChange DetectedThe changes include showing a glossary toggle, small capitalization tweaks to QC-related text (Last Update Submitted that Met QC Criteria and No FEAR Act Data), and a new page revision label (Revision: v3.4.0) replacing the previous version (v3.3.4).SummaryDifference0.3%

- Check39 days agoChange DetectedThe change is a revision update from v3.3.3 to v3.3.4, with no changes to study details, eligibility criteria, or contact information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check67 days agoChange DetectedFooter shows Revision: v3.3.3; HHS Vulnerability Disclosure and Revision: v3.3.2 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check89 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2 on the page, indicating a minor update to the page metadata. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to OMS721 Compassionate Use in TMA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the OMS721 Compassionate Use in TMA Clinical Trial page.